KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $35.4 billion.

  • Elevance Health's Cash & Current Investments rose 563.17% to $35.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $35.4 billion, marking a year-over-year increase of 563.17%. This contributed to the annual value of $35.4 billion for FY2025, which is 563.17% up from last year.
  • Per Elevance Health's latest filing, its Cash & Current Investments stood at $35.4 billion for Q4 2025, which was up 563.17% from $35.0 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Cash & Current Investments ranged from a high of $38.7 billion in Q3 2023 and a low of $31.1 billion during Q2 2021
  • Its 5-year average for Cash & Current Investments is $34.5 billion, with a median of $34.1 billion in 2021.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 3430.98% in 2021, then crashed by 788.4% in 2025.
  • Elevance Health's Cash & Current Investments (Quarter) stood at $31.1 billion in 2021, then rose by 7.04% to $33.3 billion in 2022, then rose by 8.4% to $36.1 billion in 2023, then fell by 7.34% to $33.5 billion in 2024, then increased by 5.63% to $35.4 billion in 2025.
  • Its Cash & Current Investments stands at $35.4 billion for Q4 2025, versus $35.0 billion for Q3 2025 and $33.9 billion for Q2 2025.